Demographic, Clinical, and Surgical Risk Factors of Pars Plana Vitrectomy (PPV) for Neovascular Glaucoma (NVG) Development in Type 2 Diabetes Mellitus Patients.
PMID:
GLP-1 Receptor Agonists and Sight-Threatening Ophthalmic Complications in Patients With Type 2 Diabetes.
Ramsey DJ, Makwana B, Dani SS, Patel M, Panchal K, Shah J, Khadke S, Kumar A, Patel T, Kosiborod MN, Fonarow GC, Ramsey KM, Nohria A, Butler J, Ganatra S.
JAMA Netw Open. 2025 Aug 1;8(8):e2526321. doi: 10.1001/jamanetworkopen.2025.26321.
PMID:40788647
Demographic, Clinical, and Surgical Risk Factors of Pars Plana Vitrectomy (PPV) for Neovascular Glaucoma (NVG) Development in Type 2 Diabetes Mellitus Patients.
Nisic F, Lepara O, Jahić R, Begić E, Alic L, Fajkić A.
Effect of orbital manifestations among type 2 diabetes mellitus patients.
Achwal GM, V H K, B S J.
Bioinformation. 2025 Mar 31;21(3):529-533. doi: 10.6026/973206300210529. eCollection 2025.
PMID:40599941
Plasma homocysteine levels in noninsulin-dependent diabetes mellitus with retinopathy and neovascular glaucoma.
Yücel I, Yücel G, Müftüoglu F.
Int Ophthalmol. 2004 Jul;25(4):201-5. doi: 10.1007/s10792-004-6740-8. Epub 2005 Sep 29.
PMID:16200446
Functional and structural outcomes and complications after pars plana vitrectomy for severe features of proliferative diabetic retinopathy in type 1 and type 2 diabetes mellitus.
Kaźmierczak K, Żuchowski P, Stafiej J, Malukiewicz G.
Clinical features and surgical outcomes of complications of proliferative diabetic retinopathy in young adults with type 1 diabetes mellitus versus type 2 diabetes mellitus - A comparative observational study.
Kumar K, Baliga G, Babu N, Rajan RP, Kumar G, Mishra C, Chitra R, Ramasamy K.
Indian J Ophthalmol. 2021 Nov;69(11):3289-3295. doi: 10.4103/ijo.IJO_1293_21.